The WATCHMAN Implant is a minimally invasive, one-time procedure designed to reduce the risk of strokes that originate in the Left Atrial Appendage (LAA). The WATCHMAN is a permanent implant about the size of a quarter that it is made from light compact materials commonly used for medical implants. Once installed, it offers an alternative to the lifelong use of blood thinners.
The CHAMPION-AF clinical trial aims to make FDA-approved WATCHMAN FLXTM a first-choice option versus blood thinners for stroke risk reduction in more patients with AFib. The CHAMPION‑AF clinical trial aims to expand WATCHMANTM as a first-choice option versus blood thinners to more Atrial Fibrillation (AFib)* patients.
With over 100,000 people successfully treated, this one time, FDA‑approved alternative to blood thinners may offer a lifetime of safe and effective protection against stroke.
Cardiovascular Institute of San Diego is part of the Champion Trial across 150 sites countrywide.
Learn more HERE
